Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Sci Rep ; 14(1): 6954, 2024 03 23.
Artigo em Inglês | MEDLINE | ID: mdl-38521809

RESUMO

Mucin protein glycosylation is important in determining biological properties of mucus gels, which form protective barriers at mucosal surfaces of the body such as the intestine. Ecological factors including: age, sex, and diet can change mucus barrier properties by modulating mucin glycosylation. However, as our understanding stems from controlled laboratory studies in house mice, the combined influence of ecological factors on mucin glycosylation in real-world contexts remains limited. In this study, we used histological staining with 'Alcian Blue, Periodic Acid, Schiff's' and 'High-Iron diamine' to assess the acidic nature of mucins stored within goblet cells of the intestine, in a wild mouse population (Mus musculus). Using statistical models, we identified sex as among the most influential ecological factors determining the acidity of intestinal mucin glycans in wild mice. Our data from wild mice and experiments using laboratory mice suggest estrogen signalling associates with an increase in the relative abundance of sialylated mucins. Thus, estrogen signalling may underpin sex differences observed in the colonic mucus of wild and laboratory mice. These findings highlight the significant influence of ecological parameters on mucosal barrier sites and the complementary role of wild populations in augmenting standard laboratory studies in the advancement of mucus biology.


Assuntos
Colo , Mucinas , Camundongos , Feminino , Masculino , Animais , Mucinas/metabolismo , Colo/patologia , Células Caliciformes/metabolismo , Intestinos , Estrogênios/metabolismo , Mucina-2/metabolismo , Mucosa Intestinal/metabolismo
2.
Artigo em Inglês | MEDLINE | ID: mdl-29223747

RESUMO

Parasitic nematodes infect hundreds of millions of people and farmed livestock. Further, plant parasitic nematodes result in major crop damage. The pipeline of therapeutic compounds is limited and parasite resistance to the existing anthelmintic compounds is a global threat. We have developed an INVertebrate Automated Phenotyping Platform (INVAPP) for high-throughput, plate-based chemical screening, and an algorithm (Paragon) which allows screening for compounds that have an effect on motility and development of parasitic worms. We have validated its utility by determining the efficacy of a panel of known anthelmintics against model and parasitic nematodes: Caenorhabditis elegans, Haemonchus contortus, Teladorsagia circumcincta, and Trichuris muris. We then applied the system to screen the Pathogen Box chemical library in a blinded fashion and identified compounds already known to have anthelmintic or anti-parasitic activity, including tolfenpyrad, auranofin, and mebendazole; and 14 compounds previously undescribed as anthelmintics, including benzoxaborole and isoxazole chemotypes. This system offers an effective, high-throughput system for the discovery of novel anthelmintics.


Assuntos
Anti-Helmínticos/isolamento & purificação , Automação Laboratorial/instrumentação , Ensaios de Triagem em Larga Escala/instrumentação , Nematoides/efeitos dos fármacos , Bibliotecas de Moléculas Pequenas/análise , Algoritmos , Animais , Anti-Helmínticos/química , Anti-Helmínticos/farmacologia , Automação Laboratorial/métodos , Caenorhabditis elegans/efeitos dos fármacos , Avaliação Pré-Clínica de Medicamentos , Haemonchus/efeitos dos fármacos , Infecções por Nematoides/tratamento farmacológico , Infecções por Nematoides/parasitologia , Fenótipo
3.
PLoS Negl Trop Dis ; 11(2): e0005359, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-28182663

RESUMO

Trichuris trichiura is a human parasitic whipworm infecting around 500 million people globally, damaging the physical growth and educational performance of those infected. Current drug treatment options are limited and lack efficacy against the worm, preventing an eradication programme. It is therefore important to develop new treatments for trichuriasis. Using Trichuris muris, an established model for T. trichiura, we screened a library of 480 novel drug-like small molecules for compounds causing paralysis of the ex vivo adult parasite. We identified a class of dihydrobenz[e][1,4]oxazepin-2(3H)-one compounds with anthelmintic activity against T. muris. Further screening of structurally related compounds and resynthesis of the most potent molecules led to the identification of 20 active dihydrobenzoxazepinones, a class of molecule not previously implicated in nematode control. The most active immobilise adult T. muris with EC50 values around 25-50µM, comparable to the existing anthelmintic levamisole. The best compounds from this chemotype show low cytotoxicity against murine gut epithelial cells, demonstrating selectivity for the parasite. Developing a novel oral pharmaceutical treatment for a neglected disease and deploying it via mass drug administration is challenging. Interestingly, the dihydrobenzoxazepinone OX02983 reduces the ability of embryonated T. muris eggs to establish infection in the mouse host in vivo. Complementing the potential development of dihydrobenzoxazepinones as an oral anthelmintic, this supports an alternative strategy of developing a therapeutic that acts in the environment, perhaps via a spray, to interrupt the parasite lifecycle. Together these results show that the dihydrobenzoxazepinones are a new class of anthelmintic, active against both egg and adult stages of Trichuris parasites. They demonstrate encouraging selectivity for the parasite, and importantly show considerable scope for further optimisation to improve potency and pharmacokinetic properties with the aim of developing a clinical agent.


Assuntos
Anti-Helmínticos/farmacologia , Locomoção/efeitos dos fármacos , Oxazepinas/farmacologia , Trichuris/efeitos dos fármacos , Trichuris/fisiologia , Animais , Anti-Helmínticos/química , Anti-Helmínticos/toxicidade , Sobrevivência Celular/efeitos dos fármacos , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/fisiologia , Camundongos , Oxazepinas/química , Oxazepinas/toxicidade , Tricuríase/prevenção & controle
4.
BMC Infect Dis ; 14: 520, 2014 Sep 27.
Artigo em Inglês | MEDLINE | ID: mdl-25261877

RESUMO

BACKGROUND: Trichuriasis is a parasitic disease caused by the human whipworm, Trichuris trichiura. It affects millions worldwide, particularly in the tropics. This nematode parasite burrows into the colonic epithelium resulting in inflammation and morbidity, especially in children. Current treatment relies mainly on general anthelmintics such as mebendazole but resistance to these drugs is increasingly problematic. Therefore, new treatments are urgently required. METHODS: The prospect of using the retinoid X receptor (RXR) antagonist HX531 as a novel anthelmintic was investigated by carrying out multiple viability assays with the mouse whipworm Trichuris muris. RESULTS: HX531 reduced both the motility and viability of T. muris at its L3, L4 and adult stages. Further, bioinformatic analyses show that the T. muris genome possesses an RXR-like receptor, a possible target for HX531. CONCLUSIONS: The study suggested that Trichuris-specific RXR antagonists may be a source of much-needed novel anthelmintic candidates for the treatment of trichuriasis. The identification of an RXR-like sequence in the T. muris genome also paves the way for further research based on this new anthelmintic lead compound.


Assuntos
Anti-Helmínticos/farmacologia , Benzoatos/farmacologia , Compostos de Bifenilo/farmacologia , Proteínas de Helminto/antagonistas & inibidores , Receptores X de Retinoides/antagonistas & inibidores , Trichuris/efeitos dos fármacos , Sequência de Aminoácidos , Animais , Avaliação Pré-Clínica de Medicamentos , Proteínas de Helminto/química , Proteínas de Helminto/genética , Humanos , Técnicas In Vitro , Camundongos SCID , Dados de Sequência Molecular , Receptores X de Retinoides/química , Receptores X de Retinoides/genética , Tricuríase/parasitologia , Trichuris/fisiologia
5.
J Clin Immunol ; 33(8): 1386-94, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24036839

RESUMO

PURPOSE: Vitamin A metabolites, such as all-trans-retinoic acid (RA) that act through the nuclear receptor; retinoic acid receptor (RAR), have been shown to polarise T cells towards Th2, and to be important in resistance to helminth infections. Co-incidentally, people harbouring intestinal parasites are often supplemented with vitamin A, as both vitamin A deficiency and parasite infections often occur in the same regions of the globe. However, the impact of vitamin A supplementation on gut inflammation caused by intestinal parasites is not yet completely understood. METHODS: Here, we use Trichuris muris, a helminth parasite that buries into the large intestine of mice causing mucosal inflammation, as a model of both human trichuriasis and IBD, treat with an RARα/ß agonist (Am80) and quantify the ensuing pathological changes in the gut. RESULTS: Critically, we show, for the first time, that rather than playing an anti-inflammatory role, Am80 actually exacerbates helminth-driven inflammation, demonstrated by an increased colonic crypt length and a significant CD4(+) T cell infiltrate. Further, we established that the Am80-driven crypt hyperplasia and CD4(+) T cell infiltrate were dependent on IL-6, as both were absent in Am80-treated IL-6 knock-out mice. CONCLUSIONS: This study presents novel data showing a pro-inflammatory role of RAR ligands in T. muris infection, and implies an undesirable effect for the administration of vitamin A during chronic helminth infection.


Assuntos
Benzoatos/farmacologia , Mediadores da Inflamação/farmacologia , Interleucina-6/fisiologia , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/imunologia , Tetra-Hidronaftalenos/farmacologia , Tricuríase/imunologia , Tricuríase/metabolismo , Regulação para Cima/efeitos dos fármacos , Animais , Células Cultivadas , Quimiotaxia de Leucócito/efeitos dos fármacos , Quimiotaxia de Leucócito/imunologia , Doença Crônica , Modelos Animais de Doenças , Interleucina-6/deficiência , Mucosa Intestinal/patologia , Masculino , Camundongos , Camundongos Endogâmicos AKR , Camundongos Endogâmicos C57BL , Camundongos Knockout , Receptores do Ácido Retinoico/agonistas , Tricuríase/patologia , Trichuris/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA